Subcutaneously CM310/Placebo in Patients With Moderate-to-Severe Atopic Dermatitis (AD)

Beijing Chao-Yang Hospital, Capital Medical University, Beijing

Beijing Friendship Hospital，Capital Medical University, Beijing

Peking University People's Hospital, Beijing

Peking University Third Hospital, Beijing

Chongqing Traditional Chinese Hospital, Chongqing

Dermatology Hospital of Southern Medical University, Guangzhou

Second Xiangya Hospital of Central South University, Changsha

The Third Xiangya Hospital of Central South University, Changsha

Wuxi Second Hospital, Wuxi

Affiliated Hospital of Jiangsu University, Zhenjiang

First Hospital of Jilin University, Changchun

Second Hospital of Jilin University, Changchun

Qilu Hospital of Shandong University, Jinan

Shandong Provincial Hospital of Dermatology, Jinan

Affiliated Hospital of Qingdao University, Qingdao

Yantai Yuhuangding Hospital, Yantai

Shanghai Skin Disease Hospital, Shanghai

Second Hospital of Shanxi Medical University, Taiyuan

West China Hospital of Sichuan University, Chengdu

Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin

Hangzhou First People's Hospital, Hangzhou

Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou

Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou

Zhejiang Provincial People's Hospital, Hangzhou

Ningbo Second Hospital, Ningbo